comparemela.com

Page 4 - Emotional Faces Memory Task News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA clears first digital treatment for depression, but experts caution that research is still early

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.

United statesBrian iacovielloJohn torousJohn krausDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskDigital psychiatryBeth israel deaconess medical center

FDA clears first digital treatment for depression, but experts caution that research is still early

(CNN) — The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.

United statesJohn torousJohn krausBrian iacovielloCable news network incDiscovery companyWarner brosDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskDigital psychiatryBeth israel deaconess medical centerNews network

Otsuka and Click Therapeutics Announce the U S Food and Drug Administration (FDA) Clearance of Rejoyntm, the First Prescription Digital Therapeutic Authorized for the Adjunctive Treatment of Major Depressive Disorder (MDD) Symptoms

Otsuka Pharmaceutical, Co. Ltd. (Otsuka) and Click Therapeutics, Inc., (Click) announce that the U.S. Food and Drug Administration (FDA) has cleared Rejoyntm (developed as CT-152), the first prescription digital therapeutic authorized for the.

United statesBrian iacovielloJohn krausDavid benshoof kleinWorld health organizationPatient health questionnaireOtsuka pharmaceutical development commercialization incOtsuka pharmaceutical co ltdNational institute of mental healthOtsuka america incTreatment in behavioral healthDrug administrationClick therapeutics incOtsuka holdings co ltdOtsuka america pharmaceutical incOtsuka pharmaceutical company ltd

Rejoyn Becomes First Prescription Digital Therapeutic Authorized for Treatment of MDD

The FDA has cleared the first prescription digital therapeutic for major depressive disorder, Rejoyn.

David benshoof kleinBrian iacovielloJohn krausPatient health questionnaireIcahn school of medicine at mount sinaiDrug administrationSummit artClick therapeuticsDepression rating scaleClinical global impressionEmotional faces memory taskIcahn schoolMount sinai

vimarsana © 2020. All Rights Reserved.